(Q40857892)

24 September 2017

title

The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice (English)

1 reference

24 September 2017

1 reference

6

Vitetta ES

1 reference

24 September 2017

Clinchy B

1

1 reference

24 September 2017

Gazdar A

2

1 reference

24 September 2017

Rabinovsky R

3

1 reference

24 September 2017

Yefenof E

4

1 reference

24 September 2017

Gordon B

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Breast Cancer Research and Treatment

24 September 2017

published in

1 reference

24 September 2017

volume

61

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

217-228

1 reference

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Preclinical testing of an anti-erbB-2 recombinant toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Evidence of functional lymphocytes in some (leaky) scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Breast tumor cell lines from pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

In vitro and in vivo release of soluble erbB-2 protein from human carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Outgrowth of BT-474 human breast cancer cells in immune-deficient mice: a new in vivo model for hormone-dependent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Metastasis from human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Potential of the scid mouse as a host for human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

Comparative studies between nude and scid mice on the growth and metastatic behavior of xenografted human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

ERBB2 oncogene in human breast cancer and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

erbB-2 expression in estrogen-receptor-positive breast-tumor cells is regulated by growth-modulatory reagents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Growth and metastasis of human breast carcinomas with Matrigel in athymic mice

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

MCF-7 breast cancer cells overexpressing transfectedc-erbB-2 have anin vitro growth advantage in estrogen-depleted conditions and reduced estrogen-dependence and tamoxifen-sensitivityin vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006494001861

7 January 2021

Identifiers

DOI

10.1023/A:1006494001861

1 reference

Dimensions Publication ID

24 September 2017

1031270861

0 references

1 reference